Fundraising Fox张璐
Investor合伙人 at Addor Capital
Find your path to 张璐
Sign up to see every warm intro you have to 张璐
- Paths you didn't know you had: your email and LinkedIn already hold routes to 张璐. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
张璐, trained at China Pharmaceutical University, focuses on small nucleic acid drugs, cell and gene therapies and mRNA, taking a hands-on, mechanism- and clinical-pathway-driven approach to build CDMO/drug-platform partnerships.
Colleagues at Addor Capital
Frequently asked questions
- Who is 张璐?
- 张璐, trained at China Pharmaceutical University, focuses on small nucleic acid drugs, cell and gene therapies and mRNA, taking a hands-on, mechanism- and clinical-pathway-driven approach to build CDMO/drug-platform partnerships.
- Where does 张璐 work?
- 张璐 is 合伙人 at Addor Capital.
About this profile. Compiled from public sources — Addor Capital's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights